CorInnova is a pioneering medical device company focused on developing innovative solutions for heart failure treatment. Operating in the healthcare and medical device market, CorInnova targets patients who are contraindicated for traditional left ventricular assist devices (LVADs). The company's core product is a minimally invasive, soft robotic cardiac device designed to support and potentially reverse the progression of heart failure. CorInnova's business model involves research and development, clinical trials, and partnerships with healthcare institutions and investors. Revenue is generated through product sales, licensing agreements, and funding from venture capital and grants.

Keywords: heart failure, medical device, soft robotics, minimally invasive, cardiac support, healthcare innovation, LVAD alternative, clinical trials, venture capital, patient care.